Who we are

The “Donam Plasma” Association is a non-governmental organization, established in Romania in 2021, with the main purpose of promoting human plasma donation for the manufacture of medicines.

Members of the “Donam Plasma” Association are individuals who have adhered to the goals and objectives of the association, namely doctors, patients, other individuals who voluntarily offer their support, as well as legal entities that support the goals and objectives of the association (medical professional associations, associations for patient rights, private companies in the field of human plasma collection and processing).

The founding president of the “Donam Plasma” Association is Florin Hozoc, the Romanian entrepreneur who supported convalescent plasma donation in the period of 2020-2021, offering free equipment and consumables for plasmapheresis, so that 26 transfusion centers out of the total of 40, collected convalescent plasma used to treat SARS-COV-2 infected patients.

The “Donam Plasma” Association aims to finance and develop the first 10 plasmapheresis centers in Romania in the coming years (2022-2023), with a total collection capacity of approximately 200,000 liters of human plasma for fractionation.

The 10 plasmapheresis centers that will be opened in the period 2022-2023 will function as external sections of the current public transfusion centers, in compliance with current legislation which provides that only the state can harvest blood and blood components from Romanian donors.

The transfusion centers will be developed and operated by the Association, which will mobilize private funds that will finance all costs.

All these 10 plasmapheresis centers will be subject to authorization and registration procedures in the European Plasma Master File (PMF), so that human plasma collected in these centers can be processed in European factories.

The collected human plasma will be the property of the public transfusion centers and will be offered to the manufacturers of plasma-derived medicines, in exchange for the finished products necessary for the Romanian patients. So, the medicines thus obtained will be sold to hospitals, following the normal procurement procedures, and the funds obtained will cover the costs of collection, testing, processing, storage, fractionation and promotion of donation, respectively.